Chronic hypertension in pregnancy is high blood pressure that either exists before conception or is first detected before the 20-week mark of pregnancy. The diagnostic threshold is a systolic reading above 140 or a diastolic reading above 90, measured on two separate occasions at least four hours apart. It affects a growing number of pregnancies, partly because more people are entering pregnancy at older ages or with preexisting conditions, and it carries meaningful risks for both the pregnant person and the baby when not well managed.
This is distinct from gestational hypertension, which develops after 20 weeks and resolves after delivery. If high blood pressure first appears during pregnancy but persists longer than 12 weeks postpartum, it’s reclassified as chronic hypertension, since it likely existed before pregnancy but went undetected.
Why the 20-Week Cutoff Matters
Blood pressure naturally drops during pregnancy, reaching its lowest point between weeks 14 and 28. This dip can temporarily mask preexisting hypertension. A person with undiagnosed high blood pressure might have perfectly normal readings at their first prenatal visit, only to see their numbers climb again in the second half of pregnancy. When that happens, it can look like a new problem when it’s actually an old one resurfacing.
This is why the 20-week dividing line exists. Blood pressure that’s elevated before that point almost certainly reflects a chronic condition. If elevated readings only appear after 20 weeks in someone who previously tested normal, the working diagnosis shifts to either gestational hypertension or preeclampsia, both of which have different implications and management strategies.
Mild vs. Severe Classification
Chronic hypertension in pregnancy is categorized into two tiers. Mild chronic hypertension means systolic pressure above 140 or diastolic above 90. Severe chronic hypertension means systolic pressure above 160 or diastolic above 110. The severity classification directly affects how aggressively the condition is treated and how early delivery may be recommended.
Risks to the Pregnant Person
The most significant risk is superimposed preeclampsia, a dangerous complication where organ damage develops on top of the existing high blood pressure. Between 17% and 25% of pregnant people with chronic hypertension develop superimposed preeclampsia, compared to the roughly 3% to 5% preeclampsia rate in the general pregnant population. A large trial of 822 women with chronic hypertension found the rate was 22%.
Superimposed preeclampsia is diagnosed when someone with chronic hypertension develops new signs of organ stress: dropping platelet counts, impaired liver function, kidney problems, or neurological symptoms like severe headaches and vision changes. Kidney involvement and protein in the urine remain the most common features, appearing in about 75% of preeclampsia cases.
Placental abruption, where the placenta separates from the uterine wall before delivery, is also more common. National data show an abruption rate of about 1.5% in women with chronic hypertension versus 0.6% in those without, roughly 2.4 times the risk. That rate climbs to around 3% when superimposed preeclampsia is also present. Severely elevated blood pressure also raises the risk of stroke, though this remains uncommon overall.
Risks to the Baby
High blood pressure can compromise blood flow through the placenta, which is the baby’s sole source of oxygen and nutrients. This can lead to fetal growth restriction, where the baby grows more slowly than expected. It also increases the likelihood of preterm birth, either because labor begins spontaneously or because early delivery becomes medically necessary to protect the parent’s health.
Because of these concerns, pregnancies with chronic hypertension receive closer monitoring than typical pregnancies. Starting at 32 weeks, fetal surveillance is recommended. This usually includes weekly testing to check on the baby’s heart rate patterns and amniotic fluid levels, along with growth ultrasounds every three to four weeks during the third trimester to ensure the baby is gaining weight appropriately.
How Blood Pressure Is Managed During Pregnancy
For years, there was genuine uncertainty about whether treating mild chronic hypertension during pregnancy actually helped or might restrict the baby’s growth by reducing placental blood flow too much. A landmark trial published in the New England Journal of Medicine, known as the CHAP trial, settled this question. Pregnant women with mild chronic hypertension who were treated to a target below 140/90 had better pregnancy outcomes than those who only received medication if their blood pressure reached severe levels (160/105 or higher). Importantly, the treated group did not have higher rates of undersized babies.
This shifted clinical practice. The current approach is to actively treat chronic hypertension during pregnancy with a target of keeping blood pressure below 140/90, rather than waiting for it to reach dangerous levels. The medications used are ones with long safety records in pregnancy, most commonly labetalol (a blood pressure pill that slows the heart rate and relaxes blood vessels) and nifedipine (a calcium channel blocker).
Preventing Superimposed Preeclampsia
Because the risk of superimposed preeclampsia is so high, prevention is a key part of care. Low-dose aspirin (81 mg daily) is recommended for all pregnant people with chronic hypertension. It should be started between 12 and 28 weeks, with the best results seen when it’s initiated before 16 weeks. It’s continued daily until delivery. This simple, inexpensive intervention meaningfully reduces preeclampsia risk, though it doesn’t eliminate it entirely.
When Delivery Is Recommended
The timing of delivery depends on how well blood pressure is controlled and whether complications develop. For someone with well-managed mild chronic hypertension and no signs of preeclampsia, delivery is typically planned in the late preterm to early term window rather than waiting for a full 40 weeks. If blood pressure is in the severe range or superimposed preeclampsia develops, delivery may need to happen earlier. The exact timing is individualized based on the balance between the risks of continued pregnancy and the baby’s readiness for life outside the womb.
Postpartum Blood Pressure Care
Blood pressure doesn’t normalize the moment delivery is over. In fact, it often spikes in the first few days postpartum, making this a period that requires careful monitoring. The postpartum period for blood pressure management extends through at least six weeks after delivery, and increasingly, clinicians view the entire “fourth trimester” (the first 12 weeks) as a time requiring ongoing attention.
For those who are breastfeeding, several blood pressure medications are considered safe because they transfer to breast milk in only minimal amounts. Labetalol, nifedipine, and amlodipine all fall into this category. ACE inhibitors like enalapril, which are not used during pregnancy because of risks to the developing baby, can be safely started after delivery and are also compatible with breastfeeding. Hydrochlorothiazide, a common diuretic, is acceptable at lower doses but may reduce milk supply at higher amounts.
People with chronic hypertension will need ongoing blood pressure management well beyond pregnancy. For some, pregnancy serves as the first time their hypertension is detected, making postpartum follow-up an opportunity to establish long-term cardiovascular care.